ALPS Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
1,239
-78
| -6% | -$34.7K | ﹤0.01% | 612 |
|
|
2025
Q1 | $639K | Buy |
1,317
+529
| +67% | +$256K | ﹤0.01% | 555 |
|
|
2024
Q4 | $317K | Sell |
788
-17
| -2% | -$6.85K | ﹤0.01% | 857 |
|
|
2024
Q3 | $374K | Sell |
805
-1,327
| -62% | -$617K | ﹤0.01% | 718 |
|
|
2024
Q2 | $999K | Buy |
2,132
+80
| +4% | +$37.5K | 0.01% | 463 |
|
|
2024
Q1 | $858K | Sell |
2,052
-291
| -12% | -$122K | 0.01% | 519 |
|
|
2023
Q4 | $953K | Sell |
2,343
-311
| -12% | -$127K | 0.01% | 492 |
|
|
2023
Q3 | $923K | Buy |
2,654
+183
| +7% | +$63.6K | 0.01% | 484 |
|
|
2023
Q2 | $870K | Buy |
2,471
+839
| +51% | +$295K | 0.01% | 520 |
|
|
2023
Q1 | $514K | Sell |
1,632
-995
| -38% | -$313K | ﹤0.01% | 589 |
|
|
2022
Q4 | $759K | Sell |
2,627
-120
| -4% | -$34.7K | 0.01% | 525 |
|
|
2022
Q3 | $795K | Buy |
2,747
+411
| +18% | +$119K | 0.01% | 514 |
|
|
2022
Q2 | $658K | Buy |
2,336
+97
| +4% | +$27.3K | 0.01% | 535 |
|
|
2022
Q1 | $584K | Sell |
2,239
-792
| -26% | -$207K | 0.01% | 412 |
|
|
2021
Q4 | $666K | Sell |
3,031
-354
| -10% | -$77.8K | 0.01% | 451 |
|
|
2021
Q3 | $614K | Buy |
3,385
+1,614
| +91% | +$293K | 0.01% | 474 |
|
|
2021
Q2 | $357K | Sell |
1,771
-63
| -3% | -$12.7K | ﹤0.01% | 673 |
|
|
2021
Q1 | $394K | Sell |
1,834
-1,432
| -44% | -$308K | ﹤0.01% | 518 |
|
|
2020
Q4 | $772K | Sell |
3,266
-272
| -8% | -$64.3K | 0.01% | 417 |
|
|
2020
Q3 | $963K | Buy |
3,538
+1,323
| +60% | +$360K | 0.01% | 358 |
|
|
2020
Q2 | $643K | Buy |
2,215
+1,149
| +108% | +$334K | 0.01% | 411 |
|
|
2020
Q1 | $254K | Sell |
1,066
-921
| -46% | -$219K | ﹤0.01% | 557 |
|
|
2019
Q4 | $435K | Sell |
1,987
-87
| -4% | -$19K | ﹤0.01% | 532 |
|
|
2019
Q3 | $351K | Sell |
2,074
-21
| -1% | -$3.55K | ﹤0.01% | 742 |
|
|
2019
Q2 | $384K | Sell |
2,095
-112
| -5% | -$20.5K | ﹤0.01% | 685 |
|
|
2019
Q1 | $406K | Buy |
+2,207
| New | +$406K | ﹤0.01% | 670 |
|